Cargando…

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients

It is becoming increasingly clear that longer duration of untreated psychosis (DUP) is associated with adverse clinical outcomes in patients with psychosis spectrum disorders. Because this association is often cited when justifying early intervention efforts, it is imperative to better understand un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kraguljac, Nina Vanessa, Anthony, Thomas, Morgan, Charity Johanna, Jindal, Ripu Daman, Burger, Mark Steven, Lahti, Adrienne Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658031/ https://www.ncbi.nlm.nih.gov/pubmed/32398721 http://dx.doi.org/10.1038/s41380-020-0765-x

Ejemplares similares

T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS
por: Kraguljac, Nina, et al.
Publicado: (2020)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients
por: Birur, Badari, et al.
Publicado: (2020)

Aberrant static and dynamic functional patterns of frontoparietal control network in antipsychotic‐naïve first‐episode psychosis subjects
por: Briend, Frederic, et al.
Publicado: (2020)

Structural and Functional Default Mode Network Connectivity and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Maximo, Jose O, et al.
Publicado: (2021)

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

M169. HIPPOCAMPAL GLUTAMATE AND HIPPOCAMPUS SUBFIELD VOLUMES IN ANTIPSYCHOTIC-NAIVE FIRST EPISODE PSYCHOSIS SUBJECTS AND RELATIONSHIPS TO DURATION OF UNTREATED PSYCHOSIS
Publicado: (2020)

Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
por: Nelson, Eric A., et al.
Publicado: (2022)

S79. REINFORCEMENT LEARNING ABNORMALITIES IN INDIVIDUALS AT CLINICAL HIGH RISK AND IN THE FIRST EPISODE OF PSYCHOSIS
por: Datta, Raktima, et al.
Publicado: (2020)

T135. NEIGHBORHOOD-LEVEL PREDICTORS OF AGE AT ONSET AND DURATION OF UNTREATED PSYCHOSIS IN FIRST-EPISODE PSYCHOSIS
por: Ku, Benson, et al.
Publicado: (2018)

Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi
por: Myaba, Japhet, et al.
Publicado: (2021)

F186. TAPETUM ABNORMALITIES IN FIRST-EPISODE PSYCHOSIS AND RELATIONSHIP TO SYMPTOM SEVERITY AND DURATION OF UNTREATED PSYCHOSIS
por: Lee, Sun Woo, et al.
Publicado: (2018)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
por: Becklén, Meneca, et al.
Publicado: (2021)

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
por: Ermakova, Anna O., et al.
Publicado: (2018)

Examining evidence for neighbourhood variation in the duration of untreated psychosis
por: Kirkbride, J.B., et al.
Publicado: (2010)

Association between duration of Untreated Psychosis and severer symptoms and poorer quality of life: study in First-Episode Psychosis patients
por: Pires, A. C. M., et al.
Publicado: (2023)

Impact of duration of untreated psychosis on the treatment outcome among first episode schizophrenia patients.
por: Fatima, Syeda Nissar, et al.
Publicado: (2022)

A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis
por: Overbeek, Gregory, et al.
Publicado: (2021)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Association between referral source and duration of untreated psychosis in pathways to care among first episode psychosis patients in Northern Malawi
por: Kaminga, Atipatsa C., et al.
Publicado: (2019)

Searching for psychosis: INTREPID (1): systems for detecting untreated and first-episode cases of psychosis in diverse settings
por: Morgan, Craig, et al.
Publicado: (2015)

Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2010)

Insulin resistance in first episode antipsychotic naïve psychosis patients-A cross sectional study.
por: Akshatha, C J, et al.
Publicado: (2022)

Treatments for chronic psychosis
por: Tamminga, Carol A., et al.
Publicado: (2001)

Duration of Untreated Psychosis Is Associated with Temporal and Occipitotemporal Gray Matter Volume Decrease in Treatment Naïve Schizophrenia
por: Guo, Xiaofeng, et al.
Publicado: (2013)

Antipsychotic prescribing choices in patients with First Episode Psychosis
por: Fallon, J., et al.
Publicado: (2022)

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia
por: Barnes, Thomas R. E., et al.
Publicado: (2008)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study
por: Knolle, Franziska, et al.
Publicado: (2018)

Duration of Untreated Psychosis in Chinese and Mauritian: Impact of Clinical Characteristics and Patients’ and Families’ Perspectives on Psychosis
por: Devi Thakoor, Jaya Prishni, et al.
Publicado: (2016)

O2.2. EVALUATION OF THE RELATIONSHIP BETWEEN GLUTAMATE AND BRAIN CONNECTIVITY IN ANTIPSYCHOTIC-NAïVE FIRST EPISODE PATIENTS – A COMBINED MAGNETIC RESONANCE SPECTROSCOPY AND RESTING STATE FUNCTIONAL CONNECTIVITY MRI STUDY
por: Maximo, Jose, et al.
Publicado: (2020)

Ethnic variations in duration of untreated psychosis: report from the CRIS-FEP study
por: Oduola, Sherifat, et al.
Publicado: (2020)

Pathways to Care: Duration of Untreated Psychosis from Karachi, Pakistan
por: Naqvi, Haider A., et al.
Publicado: (2009)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

What are the physical and mental health implications of duration of untreated psychosis?
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

A multimodal magnetoencephalography 7 T fMRI and 7 T proton MR spectroscopy study in first episode psychosis
por: Gawne, Timothy J., et al.
Publicado: (2020)

Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
por: Waddington, John L.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4hn4vvg89jpgf83cb0159vi4lj